Osteogenic Potential of a Biomaterial Enriched with Osteostatin and Mesenchymal Stem Cells in Osteoporotic Rabbits

Gonzalo Luengo-Alonso,Beatriz Bravo-Gimenez,Daniel Lozano,Clara Heras,Sandra Sanchez-Salcedo,Lorena Benito-Garzón,Monica Abella,María Vallet-Regi,David Cecilia-Lopez,Antonio J. Salinas
DOI: https://doi.org/10.3390/biom14020143
IF: 6.064
2024-01-24
Biomolecules
Abstract:Mesoporous bioactive glasses (MBGs) of the SiO2–CaO–P2O5 system are biocompatible materials with a quick and effective in vitro and in vivo bioactive response. MBGs can be enhanced by including therapeutically active ions in their composition, by hosting osteogenic molecules within their mesopores, or by decorating their surfaces with mesenchymal stem cells (MSCs). In previous studies, our group showed that MBGs, ZnO-enriched and loaded with the osteogenic peptide osteostatin (OST), and MSCs exhibited osteogenic features under in vitro conditions. The aim of the present study was to evaluate bone repair capability after large bone defect treatment in distal femur osteoporotic rabbits using MBGs (76%SiO2–15%CaO–5%P2O5–4%ZnO (mol-%)) before and after loading with OST and MSCs from a donor rabbit. MSCs presence and/or OST in scaffolds significantly improved bone repair capacity at 6 and 12 weeks, as confirmed by variations observed in trabecular and cortical bone parameters obtained by micro-CT as well as histological analysis results. A greater effect was observed when OST and MSCs were combined. These findings may indicate the great potential for treating critical bone defects by combining MBGs with MSCs and osteogenic peptides such as OST, with good prospects for translation to clinical practice.
biochemistry & molecular biology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to evaluate the bone repair ability of using mesoporous bioactive glass (MBGs) composites rich in osteogenic molecules (such as osteogenic peptide Osteostatin, abbreviated as OST) and mesenchymal stem cells (abbreviated as MSCs) in an osteoporosis rabbit model to treat large - segment bone defects. Specifically, the study aims to observe, through micro - CT analysis and histological analysis, the effects of using differently treated MBGs (76%SiO_2–15%CaO–5%P_2O_5–4%ZnO) on trabecular and cortical bone parameters at 6 and 12 weeks, and whether these treatments can significantly improve the bone repair ability. The research background mentions that osteoporosis is a metabolic disease that leads to a decrease in bone density, which makes bone repair more difficult. Therefore, the development of effective treatment methods is of great significance for clinical applications. The MBGs used in the paper is a material with good biocompatibility and a rapid in - vivo bioactive response. By introducing zinc ions (Zn^2+) into its structure and loading OST and MSCs, its ability to promote osteogenesis can be further enhanced. The ultimate goal of the study is to explore the potential of this composite material in treating large - segment bone defects that are difficult to heal clinically.